Biomanufacturer Organogenesis secures entire 100 Technology Way in Smithfield

According to the New England Real Estate Journal, Organogenesis Holdings Inc. has signed a full-building lease for a 123,000-square-foot biomanufacturing facility at 100 Technology Way, Smithfield, owned by The Davis Companies. The regenerative medicine firm will expand its production capabilities at the site, which is undergoing upgrades to meet cGMP standards and is supported by robust utility infrastructure. Located just off Interstate 295, the facility offers strategic access to the Boston and Cambridge life sciences corridor.

Click Here: Organogenesis Holdings leases 123,000 s/f at The Davis Cos.’ 100 Technology Way for more information.